152 related articles for article (PubMed ID: 14558924)
1. Possible induction of Graves' disease and painless thyroiditis by gonadotropin-releasing hormone analogues.
Amino N; Hidaka Y; Takano T; Tatsumi KI; Izumi Y; Nakata Y
Thyroid; 2003 Aug; 13(8):815-8. PubMed ID: 14558924
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
Izumi Y; Takeoka K; Amino N
Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
[TBL] [Abstract][Full Text] [Related]
3. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
4. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy.
Kung AW; Lau KS; Kohn LD
J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791
[TBL] [Abstract][Full Text] [Related]
5. Simple and practical parameters for differentiation between destruction-induced thyrotoxicosis and Graves' thyrotoxicosis.
Izumi Y; Hidaka Y; Tada H; Takano T; Kashiwai T; Tatsumi KI; Ichihara K; Amino N
Clin Endocrinol (Oxf); 2002 Jul; 57(1):51-8. PubMed ID: 12100069
[TBL] [Abstract][Full Text] [Related]
6. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
Wood LC; Ingbar SH
J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
[TBL] [Abstract][Full Text] [Related]
7. A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis.
Iitaka M; Ishii J; Ishikawa N; Yoshimura H; Momotani N; Saitou H; Ito K
Endocrinol Jpn; 1991 Dec; 38(6):667-71. PubMed ID: 1688049
[TBL] [Abstract][Full Text] [Related]
8. Ratio of serum free triiodothyronine to free thyroxine in Graves' hyperthyroidism and thyrotoxicosis caused by painless thyroiditis.
Yoshimura Noh J; Momotani N; Fukada S; Ito K; Miyauchi A; Amino N
Endocr J; 2005 Oct; 52(5):537-42. PubMed ID: 16284430
[TBL] [Abstract][Full Text] [Related]
9. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of thyroxine administration on elevated thyroid stimulating hormone receptor antibody levels in treated Graves' disease patients.
Tamai H; Hayaki I; Kawai K; Komaki G; Matsubayashi S; Kuma K; Kumagai LF; Nagataki S
J Clin Endocrinol Metab; 1995 May; 80(5):1481-4. PubMed ID: 7744989
[TBL] [Abstract][Full Text] [Related]
11. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
Amino N; Yabu Y; Miki T; Morimoto S; Kumahara Y; Mori H; Iwatani Y; Nishi K; Nakatani K; Miyai K
J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
[TBL] [Abstract][Full Text] [Related]
12. Partial characterization and clinical correlation of circulating human immunoglobulins directed against thyrotrophin binding sites in guinea pig fat cell membranes. Development of a direct enzyme immunoassay.
Baker JR; Lukes YG; Smallridge RC; Berger M; Burman KD
J Clin Invest; 1983 Oct; 72(4):1487-97. PubMed ID: 6138364
[TBL] [Abstract][Full Text] [Related]
13. Serial changes in liver function tests in patients with thyrotoxicosis induced by Graves' disease and painless thyroiditis.
Kubota S; Amino N; Matsumoto Y; Ikeda N; Morita S; Kudo T; Ohye H; Nishihara E; Ito M; Fukata S; Miyauchi A
Thyroid; 2008 Mar; 18(3):283-7. PubMed ID: 18001177
[TBL] [Abstract][Full Text] [Related]
14. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
[TBL] [Abstract][Full Text] [Related]
15. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
16. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease.
Amino N; Tanizawa O; Mori H; Iwatani Y; Yamada T; Kurachi K; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Jul; 55(1):108-12. PubMed ID: 6896207
[TBL] [Abstract][Full Text] [Related]
17. Decrease of immunoglobulin G-Fc receptor-bearing T lymphocytes in Graves' disease.
Mori H; Amino N; Iwatani Y; Asari S; Izumiguchi Y; Kumahara Y; Miyai K
J Clin Endocrinol Metab; 1982 Sep; 55(3):399-402. PubMed ID: 6178751
[TBL] [Abstract][Full Text] [Related]
18. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
19. Pituitary-thyroid regulation in euthyroid patients with Graves' disease previously treated with antithyroid drugs.
Buerklin EM; Schimmel M; Utiger RD
J Clin Endocrinol Metab; 1976 Aug; 43(2):419-27. PubMed ID: 59733
[TBL] [Abstract][Full Text] [Related]
20. Graves' disease following subacute thyroiditis.
Nakano Y; Kurihara H; Sasaki J
Tohoku J Exp Med; 2011 Dec; 225(4):301-9. PubMed ID: 22112923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]